Summary: In this interview with Pharmtech, Karunakar Sukuru, Global Vice President, Rx Product Development, Pharma and Consumer Health, Catalent shares his thoughts on the key benefits of Lipid based formulations (LBF.)
Summary: This executive summary showcases examples of real-life tactical and operational decisions involved in the integrated approach to drug development.
Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.
Summary: Catalent’s Nottingham facility specializes in early phase development of small molecule drug candidates and complex molecules from bench to clinic through integrated offerings such as…
Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.
Industry experts discuss how QbD strategies can be applied in the systematic evaluation of small batches of spray-dried solid dispersions for oral delivery.
